Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma
Clinical trial NCT01445340 · TERMINATED
Trial details
- NCT number
- NCT01445340
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-21
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.